uniQure Announces Financial Results For Third Quarter 2016 and Provides Update on Company Progress
Nov 22, 2016 12:06 pm UTC| Business
~ Strategic Review Completed to Refocus Pipeline, Reduce Operating Costs and Deliver Long-Term Shareholder Value ~ Updated Clinical Data on AMT-060 in Hemophilia B at Upcoming ASH Annual MeetingLEXINGTON, Mass. and...
Elbit Vision Systems Announces Third Quarter 2016 Results
Nov 22, 2016 12:00 pm UTC| Business
Revenues at $2.5 million Net Income of $528 thousand Third Quarter 2016 highlights Revenue of $2.5 million with continued sequential growth expected into Q4;Gross and operating margins at 54.9% and 22.3%,...
uniQure Announces Financial Results For Third Quarter 2016 and Provides Update on Company Progress
Nov 22, 2016 12:00 pm UTC| Business
~ Strategic Review Completed to Refocus Pipeline, Reduce Operating Costs and DeliverLong-Term Shareholder Value ~ Updated Clinical Data on AMT-060 in Hemophilia B at Upcoming ASH Annual Meeting LEXINGTON, Mass. and...
GDS Holdings Limited to Report Third Quarter 2016 Financial Results on Monday, December 5, 2016
Nov 22, 2016 12:00 pm UTC| Business
SHANGHAI, China, Nov. 22, 2016 -- GDS Holdings Limited (the “Company”) (NASDAQ:GDS), a leading developer and operator of high-performance data centers in China, today announced that it will report its third quarter 2016...
Nov 22, 2016 12:00 pm UTC| Business
NEW YORK, Nov. 22, 2016 -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL) today announced a positive 41-week update from its Phase 2a study in mild-to-moderate Alzheimer’s disease (AD) patients for...
Mitek to Attend the Benchmark Discovery Conference in Chicago on December 1, 2016
Nov 22, 2016 12:00 pm UTC| Business
SAN DIEGO, Nov. 22, 2016 -- Mitek (NASDAQ:MITK) (www.miteksystems.com), a global leader in mobile capture and identity verification software solutions, today announced that Russ Clark, CFO will be participating in the...
Nov 22, 2016 12:00 pm UTC| Business
NEW YORK, Nov. 22, 2016 -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) ("Actinium" or "the Company"), a biopharmaceutical company developing innovative targeted therapies for cancers lacking effective treatment...